Researcher
Thomas Dawson earned his PhD in pharmacology from the University of North Carolina in 1994. He then joined the Duke University Medical Center from 1994-1996 as a Pediatric Clinical Medical Genetics Fellow. From 1998-2015 he worked in Procter & Gamble’s Beauty Technology Division, before joining A*STAR’s Institute of Medical Biology (IMB) to develop and lead translational programs in hair and scalp biology. In 2018, Dawson moved to the Skin Research Institute of Singapore (SRIS) and the A*STAR Skin Research Institute (A*SRL), where he is currently the Deputy Executive Director. Dawson has over 30 years of research experience in end-to-end drug discovery, 30 granted patents, multiple products in the market, and a unique background in skin, hair and microbiome research.
Related Articles
Breakaway yeasts instigate the itch
22 Feb 2024Researchers discover a protein-cutting enzyme that may be responsible for inflammatory skin conditions triggered by
Dusting away dandruff
5 Apr 2021Zinc pyrithione shampoos tower above other antifungals for keeping dandruff at bay, an A*STAR study
Figuring out the fungi that live on and inside us
30 Aug 2019Recent progress in our understanding of Malassezia fungi is helping to unlock the secrets of
Acne problems are more than skin deep
30 Aug 2019A review by A*STAR researchers highlights the need to better understand the role of the